Prognostic Value of Metastatic Axillary Lymph Node Ratio for Chinese Breast Cancer Patients

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Wu, San Gang ^a   He, Zhen Yu ^a   Li, Qun ^b   Sun, Jia Yuan ^b   Li, Feng Yan ^b   Lin, Qin ^a   Lin, Huan Xin ^b   Guan, Xun Xing ^b  

^a THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PROGESTERONE RECEPTOR; TAXANE DERIVATIVE; BIOLOGICAL MARKER; ERBB2 PROTEIN, HUMAN;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER PROGNOSIS; CANCER STAGING; CHINESE; DISEASE FREE SURVIVAL; DISTANT METASTASIS FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; LYMPH NODE RATIO; MAJOR CLINICAL STUDY; MASTECTOMY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; RETROSPECTIVE STUDY; ASIAN CONTINENTAL ANCESTRY GROUP; AXILLA; BREAST NEOPLASMS; GENE EXPRESSION; GENETICS; LYMPH NODE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; AXILLA; BIOLOGICAL MARKERS; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES;

EID: 84876575084     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061410     Document Type: Article

References (24)

1. Rosen PR, Groshen S, Saigo PE, Kinne DW, Hellman S, (1989) A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol 7: 355-366.
2. Vinh-Hung V, Cserni G, Burzykowski T, van de Steene J, Voordeckers M, et al. (2003) Effect of the number of uninvolved nodes on survival in early breast cancer. Oncol Rep 10: 363-368.
3. Vinh-Hung V, Burzykowski T, Cserni G, Voordeckers M, Van De Steene J, et al. (2003) Functional form of the effect of the numbers of axillary nodes on survival in early breast cancer. Int J Oncol 22: 697-704.
4. Carter CL, Allen C, Henson DE, (1989) Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63: 181-187.
5. Axelsson CK, Mouridsen HT, Zedeler K, (1992) Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur J Cancer 28A: 1415-1418.
6. Recht A, Gray R, Davidson NE, Fowble BL, Solin LJ, et al. (1999) Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol 17: 1689-1700.
7. Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, et al. (2002) Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20: 3628-3636.
8. Danko ME, Bennett KM, Zhai J, Marks JR, Olson JA Jr. (2010) Improved staging in node-positive breast cancer patients using lymph node ratio: results in 1,788 patients with long-term follow-up. J Am Coll Surg 210: 797-805.e1, 805-807.
9. Anonymity (1991) NIH consensus conference. Treatment of early-stage breast cancer. JAMA 265: 391-395.
10. Voordeckers M, Vinh-Hung V, Van de Steene J, Lamote J, Storme G, (2004) The lymph node ratio as prognostic factor in node-positive breast cancer. Radiother Oncol 70: 225-230.
11. Woodward WA, Vinh-Hung V, Ueno NT, Cheng YC, Royce M, et al. (2006) Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol 24: 2910-2916.
12. Vinh-Hung V, Verschraegen C, Promish DI, Cserni G, Van de Steene J, et al. (2004) Ratios of involved nodes in early breast cancer. Breast Cancer Res 6: R680-R688.
13. van der Wal BC, Butzelaar RM, van der Meij S, Boermeester MA, (2002) Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer. Eur J Surg Oncol 28: 481-489.
14. Vinh-Hung V, Verkooijen HM, Fioretta G, Neyroud-Caspar I, Rapiti E, et al. (2009) Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol 27: 1062-1068.
15. Chagpar AB, Camp RL, Rimm DL, (2011) Lymph node ratio should be considered for incorporation into staging for breast cancer. Ann Surg Oncol 18: 3143-3148.
16. Ahn SH, Kim HJ, Lee JW, Gong GY, Noh DY, et al. (2011) Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society. Breast Cancer Res Treat 130: 507-515.
17. Wang F, He W, Qiu H, Wang X, Guo G, et al. (2012) Lymph node ratio and pN staging show different superiority as prognostic predictors depending on the number of lymph nodes dissected in chinese patients with luminal a breast cancer. Clin Breast Cancer 12: 404-411.
18. Saxena N, Hartman M, Yip CH, Bhoo-Pathy N, Khin LW, et al. (2012) Does the axillary lymph node ratio have any added prognostic value over pN staging for South East Asian breast cancer patients? PLoS One 7: e45809.
19. Yang C, Liu F, Li S, Li W, Zhai L, et al. (2012) Lymph node ratio: a new feature for defining risk category of node-positive breast cancer patients. Int J Surg Pathol 20: 546-554.
20. Vinh-Hung V, Nguyen NP, Cserni G, Truong P, Woodward W, et al. (2009) Prognostic value of nodal ratios in node-positive breast cancer: a compiled update. Future Oncol 5: 1585-1603.
21. Truong PT, Woodward WA, Thames HD, Ragaz J, Olivotto IA, et al. (2007) The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 68: 59-65.
22. Han TJ, Kang EY, Jeon W, Kim SW, Kim JH, et al. (2011) The prognostic value of the nodal ratio in N1 breast cancer. Radiat Oncol 6: 131.
23. Truong PT, Berthelet E, Lee J, Kader HA, Olivotto IA, (2005) The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Cancer 103: 2006-2014.
24. Tausch C, Taucher S, Dubsky P, Seifert M, Reitsamer R, et al. (2012) Prognostic value of number of removed lymph nodes, number of involved lymph nodes, and lymph node ratio in 7502 breast cancer patients enrolled onto trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG). Ann Surg Oncol 19: 1808-1817.